We serve Chemical Name:ebba CAS:29743-08-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ebba
CAS.NO:29743-08-6
Synonyms:4′-Ethoxybenzylidene-4-butylaniline;4-ethoxybenzylidene-4′-butylaniline;EINECS 249-821-8;p-Ethoxybenzylidene p-butylaniline;EBBA;MFCD00009465;p-ethoxybenzylidene-p-n-butylaniline
Molecular Formula:C19H23NO
Molecular Weight:281.39200
HS Code:2925290090
Physical and Chemical Properties:
Melting point:38-44 °C(lit.)
Boiling point:417.1ºC at 760 mmHg
Density:0.96 g/cm3
Index of Refraction:1.524
PSA:21.59000
Exact Mass:281.17800
LogP:5.17850
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 4′-Ethoxybenzylidene-4-butylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-ethoxybenzylidene-p-n-butylaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 249-821-8 Use and application,EBBA technical grade,usp/ep/jp grade.
Related News: For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. ebba manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. ebba supplier As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured. ebba vendor For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. ebba factory A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening.
